Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
1
x
$
30.00
VOL 4 No. 2 Full Issue - February 2002
1
x
$
20.00
Antipsychotic Induced Symptomatic Hyperprolactinemia
1
x
$
30.00
View Cart
Checkout
Home
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
“Antipsychotic Induced Symptomatic Hyperprolactinemia” has been added to your cart.
View cart
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
$
30.00
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 39 No. 1 Articles
Tags:
amy-e-brodhead
,
arif-khan
,
clinical-trials
,
k-ranga-rama-krishnan
,
medworks-media
,
placebos
,
psychopharmacology-bulletin
,
psychotropic-drugs
,
russell-l-kolts
,
suicide
,
united-states-food-and-drug-administration
,
walter-a-brown
Description
Description
Arif Khan, MD
ORIGINAL RESEARCH
Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
Arif Khan, MD, Russell L. Kolts, PhD, Amy E. Brodhead, MS, K. Ranga Krishnan, MD, and Walter A. Brown, MD
Related products
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Page load link
Go to Top